InvestorsHub Logo
Followers 7
Posts 752
Boards Moderated 0
Alias Born 05/20/2014

Re: cptjsd post# 7792

Wednesday, 05/21/2014 3:47:27 PM

Wednesday, May 21, 2014 3:47:27 PM

Post# of 140474
I agree with your statement, I took away a lot of notes, and here are a couple of the "carrots" I left with;

- 30 months of funding
- 1 year away from trials
- 40 employees at ximedica working on this product
- 20 + medical experts say the video is better than state of art
- John currently talking about partnerships/sales in Europe
- CFO - $650k monthly burn rate
- CFO - Upto $80MM in Warrant funding to fund sales and post commercialization.

My opinions:

1) 50 million warrants though could dilute and not cause PPS appreciation like we expect
2) Mgmt is now less focused on PPS and more focused on product (I'm okay with this)
3) No Reverse Split (they didn't know what it was or why they would do it) - also no thinking currently of Nasdaq uplift.

Overall I would call this a Hold/Buy, as in, hold and buy more on dips. I can see this being a $800MM dollar company next year at the same time, and with say 120mm shares outstanding, that's about $6-$7 per share.